,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,577052,118408,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,577052,118408,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,577052,118408,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,577052,118408,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,577052,118408,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,577052,118408,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,330,1,1,,577052,118408,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
7,286711,4,3,,103516472,118408,Active,,,0.0047,EC50,Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs,Confirmatory,17441706.0,
8,286712,4,4,,103516472,118408,Unspecified,,,,,Ratio of EC50 for rat L6 cells to EC50 for Plasmodium falciparum K1,Other,17441706.0,
9,286713,4,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia at 5 mg/kg intraperitoneal dose on day 4,Other,17441706.0,
10,286714,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia on 2.5 mg/kg intraperitoneal dose on day 4,Other,17441706.0,
11,286715,7,1,,103516472,118408,Inconclusive,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 5 mg/kg, intraperitoneal after 4 days",Other,17441706.0,
12,286716,6,1,,103516472,118408,Unspecified,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 10 mg/kg, intraperitoneal after 4 days",Other,17441706.0,
13,286717,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia after 2.5 mg/kg intraperitoneal dose on day 4,Other,17441706.0,
14,286718,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia after 20 mg/kg intraperitoneal dose on day 4,Other,17441706.0,
15,286719,7,1,,103516472,118408,Inconclusive,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 2.5 mg/kg, intraperitoneal after 4 days",Other,17441706.0,
16,286720,6,1,,103516472,118408,Unspecified,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 20 mg/kg, intraperitoneal after 4 days",Other,17441706.0,
17,286722,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia on 25 mg/kg/day intraperitoneal dose after 4 days,Other,17441706.0,
18,286723,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia at 50 mg/kg/day intraperitoneal dose after 4 days,Other,17441706.0,
19,286724,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia at 90 mg/kg/day intraperitoneal dose after 4 days,Other,17441706.0,
20,286725,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia at 100 mg/kg/day intraperitoneal dose after 4 days,Other,17441706.0,
21,286726,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia after 12 intraperitoneal doses of 30 mg/kg/8hrs,Other,17441706.0,
22,286727,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia after 12 doses of 15 mg/kg/8hrs,Other,17441706.0,
23,286728,3,3,,103516472,118408,Unspecified,,,,,Antimalarial activity against Plasmodium berghei NK65 infected ICR mice (Mus musculus) as reduced parasitaemia on day 4 after 1 day at 100 mg/kg/day intraperitoneal dose,Other,17441706.0,
24,286729,6,1,,103516472,118408,Unspecified,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 25 mg/kg/day, intraperitoneal after 4 days",Other,17441706.0,
25,286730,6,1,,103516472,118408,Unspecified,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 50 mg/kg/day, intraperitoneal after 4 days",Other,17441706.0,
26,286731,6,1,,103516472,118408,Unspecified,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 90 mg/kg/day, intraperitoneal after 4 days",Other,17441706.0,
27,286732,6,1,,103516472,118408,Unspecified,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 100 mg/kg/day, intraperitoneal after 4 days",Other,17441706.0,
28,286733,6,1,,103516472,118408,Unspecified,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 12 times of 30 mg/kg/8hrs, intraperitoneal",Other,17441706.0,
29,286734,6,1,,103516472,118408,Unspecified,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 12 times of 15 mg/kg/8hrs, intraperitoneal",Other,17441706.0,
30,286735,6,1,,103516472,118408,Unspecified,,,,,"Effect on survival of Plasmodium berghei NK65 infected ICR mice (Mus musculus) assessed as mean survival days at 100 mg/kg/day, intraperitoneal after 1 day",Other,17441706.0,
31,286736,6,2,,103516472,118408,Unspecified,,,,,"AUC (0-480 mins) in Wistar rat at 10 mg/kg, iv",Other,17441706.0,
32,286737,6,2,,103516472,118408,Unspecified,,,,,"AUC (0-480 mins) in Wistar rat at 10 mg/kg, po",Other,17441706.0,
33,286738,5,2,,103516472,118408,Unspecified,,,,,"Half life in Wistar rat at 10 mg/kg, iv",Other,17441706.0,
34,286739,5,2,,103516472,118408,Unspecified,,,,,"Half life in Wistar rat at 10 mg/kg, po",Other,17441706.0,
35,286740,4,1,,103516472,118408,Unspecified,,,,,"Cmax in Wistar rat at 10 mg/kg, po",Other,17441706.0,
36,286741,3,3,,103516472,118408,Unspecified,,,,,"Oral bioavailability in Wistar rat at 10 mg/kg, po",Other,17441706.0,
37,404371,6,2,,103516472,118408,Active,,,0.003,IC50,Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1,Confirmatory,18476684.0,
38,404372,3,4,,103516472,118408,Unspecified,,,,,"Selectivity index, Ratio of IC50 for rat L6 cells to IC50 for Plasmodium falciparum K1",Other,18476684.0,
39,404373,6,2,,103516472,118408,Active,,,0.036000000000000004,IC50,Antitrypanosomal activity against Trypanosoma cruzi Tulahuen C2C4,Confirmatory,18476684.0,
40,404374,3,4,,103516472,118408,Unspecified,,,,,"Selectivity index, Ratio of IC50 for rat L6 cells to IC50 for Trypanosoma cruzi Tulahuen C2C4",Other,18476684.0,
41,404375,6,2,,103516472,118408,Active,,,0.228,IC50,Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB900,Confirmatory,18476684.0,
42,404376,3,4,,103516472,118408,Unspecified,,,,,"Selectivity index, Ratio of IC50 for rat L6 cells to IC50 for Trypanosoma brucei rhodesiense STIB900",Other,18476684.0,
43,404377,6,2,,103516472,118408,Active,,,0.214,IC50,Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,Confirmatory,18476684.0,
44,404378,3,4,,103516472,118408,Unspecified,,,,,"Selectivity index, Ratio of IC50 for rat L6 cells to IC50 for Leishmania donovani MHOM-ET-67/L82 axenic amastigotes",Other,18476684.0,
45,404379,6,2,,103516472,118408,Active,,,6.7,IC50,Cytotoxicity against rat L6 cells,Confirmatory,18476684.0,
46,1259407,1,1,,363900399,118408,Inactive,,,,,CCRIS mutagenicity studies,Other,,
